脑脊液血红蛋白作为动脉瘤性蛛网膜下腔出血后继发性脑损伤监测生物标志物的前瞻性国际多中心验证研究(HeMoVal)
这项 preregistered 国际多中心队列纳入 8 个神经外科中心的 366 例患者,每日一次经脑室外引流测脑脊液血红蛋白,对继发性脑损伤的同日判别能力差(AUC 0.59),中心间异质性明显。事后探索分析中,较高的脑脊液高铁血红蛋白与继发性脑损伤相关,较高的急性期脑脊液血红蛋白与慢性脑积水和 3 个月功能预后较差相关。
要点
- 每日脑脊液血红蛋白对继发性脑损伤同日判别能力差,AUC 为 0.59。
- 8 个中心间脑脊液血红蛋白与继发性脑损伤的关联存在明显异质性。
- 事后分析中较高脑脊液高铁血红蛋白与继发性脑损伤相关。
核心结论
- 每日一次经脑室外引流测脑脊液血红蛋白对动脉瘤性蛛网膜下腔出血后继发性脑损伤的同日判别能力差,AUC 为 0.59,且中心间异质性明显。
研究设计与样本
- preregistered 国际多中心队列研究,纳入 8 个神经外科中心的 366 例患者,每日一次经脑室外引流测脑脊液血红蛋白。
主要发现
- 每日一次经脑室外引流测脑脊液血红蛋白对继发性脑损伤的同日判别能力差,AUC 为 0.59,中心间异质性明显。
- 事后探索分析中,较高的脑脊液高铁血红蛋白与继发性脑损伤相关。
- 事后探索分析中,较高的急性期脑脊液血红蛋白与慢性脑积水和 3 个月功能预后较差相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
WHAT IS ALREADY KNOWN ON THIS TOPIC Preclinical animal models link cell-free haemoglobin in cerebrospinal fluid (CSF-Hb) to secondary brain injury after aneurysmal subarachnoid haemorrhage (SAH-SBI). A single-centre study reported strong associations between daily external ventricular drain (EVD)-derived CSF-Hb levels and SAH-SBI, and suggested a strong predictive potential (area under the curve 0.89). CSF-Hb monitoring has therefore been proposed as a bedside biomarker, but it has not undergone multicentre validation. WHAT THIS STUDY ADDS In a preregistered multicentre cohort of 366 patients from eight neurosurgical centres, once-daily EVD-derived CSF-Hb measurements showed poor same-day discrimination for SAH-SBI (area under the curve 0.59) and substantial between-centre heterogeneity. In a post-hoc exploratory analysis, higher CSF methaemoglobin was associated with SAH-SBI; higher acute-phase CSF-Hb was related to chronic hydrocephalus and a worse 3 month functional outcome. HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY These...
引用
- Journal of Neurology, Neurosurgery and Psychiatry:Cerebrospinal fluid haemoglobin as a monitoring biomarker for secondary brain injury after aneurysmal subarachnoid haemorrhage: prospective international multicentre validation study (HeMoVal)
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。